Lilly announced proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting
On Sept. 16, 2020, Eli Lilly announced proof of concept data from an interim analysis of the BLAZE-1…
NanoViricides nominated a novel candidate for advancing Into clinical trials for treatment of COVID-19
On Sept. 16, 2020, NanoViricides announced that it had nominated a clinical drug candidate for the treatment of…
AIM ImmunoTech announced start of recruitment in clinical trial incorporating Ampligen in treatment of cancer patients with COVID-19
On Sept. 16, 2020, AIM ImmunoTech announced that recruitment had begun in Roswell Park Comprehensive Cancer Center’s Phase…
Factors inherent to obesity could increase vulnerability to COVID-19
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
USDA research showed higher carbohydrate and balanced fat intake can prevent certain diseases
On Sept. 15, 2020, a team of scientists in the U.S. Department of Agriculture’s (USDA) Agriculture Research Service…
NIH awarded contracts worth $228 million to develop innovative digital health technologies for COVID-19
On Sept. 15, 2020, the NIH awarded seven contracts worth a total of $22.8 million to companies and…
Laboratory testing of Brilacidin for COVID-19 in combination with remdesivir reduces viral load by nearly 100 percent
On Sept. 15, 2020, Innovation Pharma reported additional data from a U.S. Regional Biocontainment Laboratory (RBL) collected during…
FDA contracted with global partners to analyze coronavirus samples
On Sept. 15, 2020, the FDA awarded a $5.4 million research contract to the University of Liverpool and…
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Life Science History | Medical Device
FDA published comparative performance data for COVID-19 molecular diagnostic tests
On Sept. 15, 2020, the FDA published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The…
Thermo Fisher Scientific further expanded laboratory plastics production to support COVID-19 testing, therapies and vaccines
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
OPKO Health initiated clinical trial of RAYALDEE in COVID-19 patients
On Sept. 15, 2020, OPKO Health announce it had initiated a Phase 2 trial with RAYALDEEﾮ as a…
BioNTech received ﾀ375M in funding from German Federal Ministry to support COVID-19 vaccine program BNT162
On Sept. 15, 2020, BioNTech announced that had receive a grant of up to 375 million Euro from…
The US Dept of Defense awarded contracts for COVID-19 disposable isolation gowns
On Sept. 14, 2020, the U.S. Department of Defense, on behalf of the Department of Health and Human…
Valneva announced COVID-19 vaccine partnership with UK Government
On Sept. 14, 2020, Valneva announced a vaccine partnership with the UK government for its inactivated COVID-19 vaccine,…
Vaxart announced FDA clearance of IND application for oral COVID-19 vaccine
On Sept. 14, 2020, Vaxart announced that the FDA had completed its review of the Companyﾒs Investigational New…
Humanigen and Lonza announced collaboration to expand manufacturing of Humanigen’s COVID-19 therapeutic Candidate Lenzilumab
On Sept. 14, 2020, Humanigen and Lonza announced a strategic collaboration to expand the manufacturing capacity for lenzilumab…
Humanigen announced review of lenzilumab phase 3 study in COVID-19 by Data Safety Monitoring Board
On Sept. 14, 2020, Humanigen announced its Phase 3 registration trial of lenzilumab in patients with COVID-19 was…
First hospitals in the world adopt Genesis Robotic Technology for cardiac heart rhythm disorders
On Sept. 14, 2020, Stereotaxis announced it had completed installations of the worldﾒs first Genesis Robotic Magnetic Navigation…
RECOVERY COVID-19 phase 3 trial evaluated Regeneron’s REGN-COV2 investigational antibody cocktail in the UK
On Sept. 14, 2020, Regeneron and the University of Oxford announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY),…
Meridian launched novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva
On Sept. 14, 2020, Meridian Bioscience announced the launch of a novel highly sensitive SARS-CoV-2 antibody pair to…
Gilead Sciences announced acquisition of Immunomedics for $21 billion
On Sept. 13, 2020, Gilead Sciences and Immunomedics announced an agreement whereby Gilead would acquire Immunomedics for $88.00…
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
On Sept. 12 2020, Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK…
BioNTech and Pfizer proposed expansion of pivotal COVID-19 vaccine trial
On Sept. 12, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
U.S. COVID-19 cases may be substantially underestimated
On Sept. 11, 2020, UC Berkeley School of Public Health researchers reported that probability analysis showed the U.S….
Transmission of COVID-19 outbreaks associated with child care facilities in Utah
On Sept. 11, 2020, the CDC reported that twelve children acquired COVID-19 in child care facilities. One parent…
NIH ACTIV initiative launched adaptive clinical trials of blood-clotting treatments for COVID-19
On Sept. 10, 2020, the NIH launched two of three adaptive Phase 3 clinical trials evaluating the safety…
Fosun Pharma announced novel Coronavirus (2019-nCoV) RT-PCR detection Kit included in WHO Emergency Use Listing
On Sept. 10, 2020, Shanghai Fosun Pharmaceutical announced that the Novel Coronavirus (2019-nCoV) RT-PCR Detection Kit self-developed by…
Accelerate Diagnostics announced FDA Emergency Use Authorization for COVID-19 Individual IgM and IgG antibody tests
On Sept. 10, 2020, Accelerate Diagnostics and BioCheck announced that the FDA had issued an Emergency Use Authorization…
Corvus Pharmaceuticals provided update on clinical trial of CPI-006 for patients with COVID-19
On Sept. 10, 2020, Corvus Pharmaceuticals announced updated data from its ongoing Phase 1 study investigating the potential…
Merck announced positive topline results from phase 3 adult studies evaluating investigational 15-valent pneumococcal conjugate vaccine
On Sept. 9, 2020, Merck announced announced that two Phase 3 studies evaluating the safety, tolerability and immunogenicity…